Syros Pharmaceuticals, Inc. (SYRS) Insider Trading

Name: Syros Pharmaceuticals, Inc. (SYRS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Dec 4, 2024): Nancy A. Simonian (Director): Sale of 37,070 shares, $10.0K.

Get alerted when insiders trade SYRS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta